Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant

Virus-specific T-cells (VSTs) from third-party donors mediate short- and long-term antiviral effects in allogeneic hematopoietic stem cell transplant (HSCT) recipients with relapsed or refractory viral infections. We investigated early administration of third-party VSTs, together with antiviral ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wei, Clancy, Leighton E., Avdic, Selmir, Sutrave, Gaurav, Street, Janine, Simms, Renee, McGuire, Helen M., Patrick, Ellis, Chan, Adam S., McCaughan, Georgia, Myers, Nadav, Micklethwaite, Kenneth P., Antonenas, Vicki, Selim, Adrian G., Ritchie, David, Bateman, Caroline M., Shaw, Peter J., Blyth, Emily, Gottlieb, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Immunobiology and Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631614/
https://www.ncbi.nlm.nih.gov/pubmed/35819448
http://dx.doi.org/10.1182/bloodadvances.2022007103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631614/
https://www.ncbi.nlm.nih.gov/pubmed/35819448
http://dx.doi.org/10.1182/bloodadvances.2022007103

Ejemplares similares